Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

The C-terminal domain of EFA6A interacts directly with F-actin and assembles F-actin bundles.

Macia E, Partisani M, Wang H, Lacas-Gervais S, Le Clainche C, Luton F, Franco M.

Sci Rep. 2019 Dec 16;9(1):19209. doi: 10.1038/s41598-019-55630-9.

2.

HCV or HBV coinfection and lymphoma risk in people living with HIV.

Besson C, Noel N, Lancar R, Prevot S, Algarte-Genin M, Rosenthal E, Bonnet F, Meyohas MC, Partisani M, Oberic L, Gabarre J, Goujard C, Cheret A, Arvieux C, Katlama C, Salmon D, Boué F, Costello R, Hendel-Chavez H, Taoufik Y, Fontaine H, Coppo P, Mounier N, Delobel P, Costagliola D; Lymphovir and FHDH study groups.

AIDS. 2019 Dec 10. doi: 10.1097/QAD.0000000000002461. [Epub ahead of print]

PMID:
31833850
3.

Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.

Costagliola D, Potard V, Lang S, de Castro N, Cotte L, Duval X, Duvivier C, Grabar S, Mary-Krause M, Partisani M, Ronot-Bregigeon S, Simon A, Tattevin P, Weiss L, Zucman D, Katlama C, Raffi F, Boccara F.

J Infect Dis. 2020 Feb 3;221(4):516-522. doi: 10.1093/infdis/jiz481.

PMID:
31828320
4.

Treatment as prevention enrolling at least 75% of individuals on ART will be needed to significantly reduce HIV prevalence in a HIV cohort.

Jeulin H, Jeanmaire E, Murray JM, Malve B, André M, Melliez H, Lanoix JP, Hustache-Mathieu L, Partisani M, Goehringer F, May T, Schvoerer E.

J Clin Virol. 2019 Nov;120:27-32. doi: 10.1016/j.jcv.2019.08.010. Epub 2019 Aug 24.

PMID:
31541773
5.

Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.

Lupo J, Germi R, Lancar R, Algarte-Genin M, Hendel-Chavez H, Taoufik Y, Mounier N, Partisani M, Bonnet F, Meyohas MC, Marchou B, Semanova T, Prevot S, Costagliola D, Morand P, Besson C.

AIDS. 2019 May 1;33(6):993-1000. doi: 10.1097/QAD.0000000000002129.

PMID:
30946153
6.

Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status.

Baldé A, Lang S, Wagner A, Ferrières J, Montaye M, Tattevin P, Cotte L, Aslangul E, Bidégain F, Chéret A, Mary-Krause M, Meynard JL, Molina JM, Partisani M, Roger PM, Boccara F, Costagliola D.

PLoS One. 2019 Jan 16;14(1):e0210253. doi: 10.1371/journal.pone.0210253. eCollection 2019.

7.

Distribution and reduction magnitude of HIV-DNA burden in CD4+ T cell subsets depend on art initiation timing.

Gantner P, Barnig C, Partisani M, Lee GQ, Beck-Wirth G, Faller JP, Martinot M, Mosheni-Zadeh M, Cheneau C, Batard ML, Fischer P, Fuchs A, Uring-Lambert B, Bahram S, Rey D, Fafi-Kremer S.

AIDS. 2018 Apr 24;32(7):921-926. doi: 10.1097/QAD.0000000000001770.

PMID:
29424775
8.

Relapsing Pott disease caused by Mycobacterium heckeshornense in a well-controlled HIV-infected patient.

Douiri N, Lefebvre N, Hansmann Y, Partisani M, Schramm F.

Med Mal Infect. 2018 Mar;48(2):157-158. doi: 10.1016/j.medmal.2017.12.003. Epub 2018 Jan 17. No abstract available.

PMID:
29373165
9.

EFA6 proteins regulate lumen formation through α-actinin 1.

Milanini J, Fayad R, Partisani M, Lecine P, Borg JP, Franco M, Luton F.

J Cell Sci. 2018 Feb 8;131(3). pii: jcs209361. doi: 10.1242/jcs.209361.

10.

Dolutegravir reshapes the genetic diversity of HIV-1 reservoirs.

Gantner P, Lee GQ, Rey D, Mesplede T, Partisani M, Cheneau C, Beck-Wirth G, Faller JP, Mohseni-Zadeh M, Martinot M, Wainberg MA, Fafi-Kremer S.

J Antimicrob Chemother. 2018 Apr 1;73(4):1045-1053. doi: 10.1093/jac/dkx475.

PMID:
29244129
11.

Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.

Besson C, Lancar R, Prevot S, Algarte-Genin M, Delobel P, Bonnet F, Meyohas MC, Partisani M, Oberic L, Gabarre J, Goujard C, Boue F, Coppo P, Costello R, Hendel-Chavez H, Mekerri N, Dos Santos G, Recher C, Delarue R, Casasnovas RO, Taoufik Y, Mounier N, Costagliola D; ANRS-CO16 LYMPHOVIR Cohort.

AIDS. 2017 Nov 28;31(18):2493-2501. doi: 10.1097/QAD.0000000000001652.

PMID:
28926410
12.

Predictors of Standard Follow-Up Completion after Sexual Exposure to HIV: Five-Year Retrospective Analysis in a French HIV-Infection Care Center.

Gantner P, Treger M, De Miscault C, Batard ML, Bernard-Henry C, Cheneau C, De Mautort E, Partisani M, Priester M, Rey D.

PLoS One. 2015 Dec 22;10(12):e0145440. doi: 10.1371/journal.pone.0145440. eCollection 2015.

13.

High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.

Besson C, Lancar R, Prevot S, Brice P, Meyohas MC, Marchou B, Gabarre J, Bonnet F, Goujard C, Lambotte O, Boué F, Mounier N, Partisani M, Raffi F, Costello R, Hendel-Chavez H, Algarte-Genin M, Trabelsi S, Marchand L, Raphael M, Taoufik Y, Costagliola D.

Clin Infect Dis. 2015 Nov 1;61(9):1469-75. doi: 10.1093/cid/civ627. Epub 2015 Jul 29.

PMID:
26223997
14.

Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort.

Lang S, Lacombe JM, Mary-Krause M, Partisani M, Bidegain F, Cotte L, Aslangul E, Chéret A, Boccara F, Meynard JL, Pradier C, Roger PM, Tattevin P, Costagliola D, Molina JM; French Hospital Database on HIV.

PLoS One. 2015 Jul 22;10(7):e0133358. doi: 10.1371/journal.pone.0133358. eCollection 2015.

15.

Is impaired kidney function an independent predictor of the risk of myocardial infarction in HIV-infected individuals?

Lang S, Mary-Krause M, Partisani M, Gilquin J, Simon A, Cotte L, Boccara F, Costagliola D; French Hospital Database on HIV-ANRS CO4.

AIDS. 2014 Aug 24;28(13):1987-9. doi: 10.1097/QAD.0000000000000364.

PMID:
25259706
16.

Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study.

Gantner P, Koeppel C, Partisani M, Batard ML, Bernard-Henry C, Cheneau C, De Mautort E, Priester M, Muret P, Sueur C, Fafi-Kremer S, Rey D.

Scand J Infect Dis. 2014 Dec;46(12):838-45. doi: 10.3109/00365548.2014.947318. Epub 2014 Sep 17.

PMID:
25229167
17.

Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study.

Gantner P, Reinhart S, Partisani M, Baldeyrou M, Batard ML, Bernard-Henry C, Cheneau C, de Mautort E, Priester M, Fafi-Kremer S, Muret P, Rey D.

HIV Med. 2015 Feb;16(2):132-6. doi: 10.1111/hiv.12183. Epub 2014 Aug 15.

18.

EFA6B antagonizes breast cancer.

Zangari J, Partisani M, Bertucci F, Milanini J, Bidaut G, Berruyer-Pouyet C, Finetti P, Long E, Brau F, Cabaud O, Chetaille B, Birnbaum D, Lopez M, Hofman P, Franco M, Luton F.

Cancer Res. 2014 Oct 1;74(19):5493-506. doi: 10.1158/0008-5472.CAN-14-0298. Epub 2014 Aug 12.

19.

Arf6 exchange factor EFA6 and endophilin directly interact at the plasma membrane to control clathrin-mediated endocytosis.

Boulakirba S, Macia E, Partisani M, Lacas-Gervais S, Brau F, Luton F, Franco M.

Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9473-8. doi: 10.1073/pnas.1401186111. Epub 2014 Jun 16.

20.

[Reproductive options for people living with HIV: 2013 guidelines from the French expert working group].

Mandelbrot L, Berrebi A, Rouzioux C, Partisani M, Faucher P, Tubiana R, Matheron S, Bujan L, Morlat P; commission Prise en charge médicale des personnes vivant avec VIH, chapitre Désir d'enfant et grossesse.

Gynecol Obstet Fertil. 2014 Jul-Aug;42(7-8):543-50. doi: 10.1016/j.gyobfe.2014.05.019. Epub 2014 Jun 23. French.

PMID:
24969954
21.

[HIV and pregnancy: 2013 guidelines from the French expert working group].

Mandelbrot L, Berrébi A, Matheron S, Blanche S, Tubiana R, Rouzioux C, Faucher P, Partisani M, Boyer V, Taeron C, Faye A, Bujan L, Dabis F, Warszawski J, Morlat P.

J Gynecol Obstet Biol Reprod (Paris). 2014 Sep;43(7):534-48. doi: 10.1016/j.jgyn.2014.01.006. Epub 2014 Jun 17. French.

22.

Impact of late presentation on the risk of death among HIV-infected people in France (2003-2009).

Montlahuc C, Guiguet M, Abgrall S, Daneluzzi V, de Salvador F, Launay O, Martinez V, Partisani M, Pradier C, Rouveix E, Valin N, Grabar S, Costagliola D; French Hospital Database ANRS CO4 cohort.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):197-203. doi: 10.1097/QAI.0b013e31829cfbfa.

PMID:
24047970
23.

Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy.

Lacombe JM, Boue F, Grabar S, Viget N, Gazaignes S, Lascaux-Cametz AS, Pacanowski J, Partisani M, Launay O, Matheron S, Rosenthal E, Rouveix E, Tattevin P, de Truchis P, Costagliola D, Goedert JJ.

AIDS. 2013 Feb 20;27(4):635-43. doi: 10.1097/QAD.0b013e32835cba6c.

24.

Boosted protease inhibitor monotherapy as a maintenance strategy: an observational study.

Guiguet M, Ghosn J, Duvivier C, Meynard JL, Gras G, Partisani M, Teicher E, Mahamat A, Rodenbourg F, Launay O, Costagliola D; FHDH-ANRS CO4.

AIDS. 2012 Nov 28;26(18):2345-50. doi: 10.1097/QAD.0b013e32835646e0.

PMID:
22695301
25.

Arf6 negatively controls the rapid recycling of the β2 adrenergic receptor.

Macia E, Partisani M, Paleotti O, Luton F, Franco M.

J Cell Sci. 2012 Sep 1;125(Pt 17):4026-35. doi: 10.1242/jcs.102343. Epub 2012 May 18.

26.

HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals.

Lang S, Mary-Krause M, Simon A, Partisani M, Gilquin J, Cotte L, Boccara F, Costagliola D; French Hospital Database on HIV (FHDH)–ANRS CO4.

Clin Infect Dis. 2012 Aug;55(4):600-7. Epub 2012 May 18.

PMID:
22610928
27.

HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy.

Lanoy E, Rosenberg PS, Fily F, Lascaux AS, Martinez V, Partisani M, Poizot-Martin I, Rouveix E, Engels EA, Costagliola D, Goedert JJ; FHDH-ANRS CO4.

Blood. 2011 Jul 7;118(1):44-9. doi: 10.1182/blood-2011-02-339275. Epub 2011 May 6.

28.

[Assisted reproductive technique for an opiates dependant couple].

Weil M, Yu Tim Y, Reichert M, Trabelsi C, Lang JP, Ohl J, Partisani M, Habersetzer F.

Gynecol Obstet Fertil. 2011 Feb;39(2):e37-9. doi: 10.1016/j.gyobfe.2010.08.022. Epub 2011 Feb 2. French.

PMID:
21292526
29.

[Inadequate vaccination coverage in a French cohort of HIV positive patients].

Mohseni-Zadeh M, Rey D, Batard ML, Beck Wirth G, Partisani ML, Lang JM, Hansmann Y, Christmann D, Martinot M.

Med Mal Infect. 2010 Dec;40(12):683-90. doi: 10.1016/j.medmal.2010.06.005. Epub 2010 Sep 6. French.

PMID:
20822870
30.

Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.

Lang S, Mary-Krause M, Cotte L, Gilquin J, Partisani M, Simon A, Boccara F, Costagliola D; Clinical Epidemiology Group of the French Hospital Database on HIV.

Arch Intern Med. 2010 Jul 26;170(14):1228-38. doi: 10.1001/archinternmed.2010.197.

PMID:
20660842
31.

[Alterations of ovarian reserve tests in Human Immunodeficiency Virus (HIV)-infected women].

Ohl J, Partisani M, Demangeat C, Binder-Foucard F, Nisand I, Lang JM.

Gynecol Obstet Fertil. 2010 May;38(5):313-7. doi: 10.1016/j.gyobfe.2009.07.019. Epub 2010 Apr 28. French.

PMID:
20430670
32.

Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population.

Lang S, Mary-Krause M, Cotte L, Gilquin J, Partisani M, Simon A, Boccara F, Bingham A, Costagliola D; French Hospital Database on HIV-ANRS CO4.

AIDS. 2010 May 15;24(8):1228-30. doi: 10.1097/QAD.0b013e328339192f.

PMID:
20400883
33.

USP9x-mediated deubiquitination of EFA6 regulates de novo tight junction assembly.

Théard D, Labarrade F, Partisani M, Milanini J, Sakagami H, Fon EA, Wood SA, Franco M, Luton F.

EMBO J. 2010 May 5;29(9):1499-509. doi: 10.1038/emboj.2010.46. Epub 2010 Mar 25.

34.

EFA6 facilitates the assembly of the tight junction by coordinating an Arf6-dependent and -independent pathway.

Klein S, Partisani M, Franco M, Luton F.

J Biol Chem. 2008 Oct 31;283(44):30129-38. doi: 10.1074/jbc.M803375200. Epub 2008 Sep 8.

35.

The pleckstrin homology domain of the Arf6-specific exchange factor EFA6 localizes to the plasma membrane by interacting with phosphatidylinositol 4,5-bisphosphate and F-actin.

Macia E, Partisani M, Favard C, Mortier E, Zimmermann P, Carlier MF, Gounon P, Luton F, Franco M.

J Biol Chem. 2008 Jul 11;283(28):19836-44. doi: 10.1074/jbc.M800781200. Epub 2008 May 19.

36.

[The desire to become a parent when infected with human immunodeficiency virus, hepatitis C virus or hepatitis B virus].

Ohl J, Partisani M.

Gynecol Obstet Fertil. 2007 Oct;35(10):1035-8. Epub 2007 Sep 25. French.

PMID:
17897865
37.

Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response.

Fardet L, Mary-Krause M, Heard I, Partisani M, Costagliola D; French Hospital Database on HIV.

HIV Med. 2006 Nov;7(8):520-9.

38.

Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients.

Rey D, Krebs M, Partisani M, Hess G, Cheneau C, Priester M, Bernard-Henry C, de Mautort E, Lang JM.

J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):530-4.

PMID:
17057610
39.

[Hepatitis A seroprevalence in HIV-infected patients].

Rey D, Frick-Michot E, Partisani M, Hess-Kempf G, Cheneau C, Priester M, Bernard-Henry C, de Mautort E, Wendling MJ, Meyer P, Lang JM.

Med Mal Infect. 2005 Jul-Aug;35(7-8):402-6. French.

PMID:
16139462
40.

Encouraging results despite complexity of multidisciplinary care of HIV-infected women using assisted reproduction techniques.

Ohl J, Partisani M, Wittemer C, Lang JM, Viville S, Favre R.

Hum Reprod. 2005 Nov;20(11):3136-40. Epub 2005 Jul 8.

PMID:
16006462
41.

The small G-protein Arf6GTP recruits the AP-2 adaptor complex to membranes.

Paleotti O, Macia E, Luton F, Klein S, Partisani M, Chardin P, Kirchhausen T, Franco M.

J Biol Chem. 2005 Jun 3;280(22):21661-6. Epub 2005 Mar 31.

42.

Tolerance of a short course of nevirapine, associated with 2 nucleoside analogues, in postexposure prophylaxis of HIV.

Rey D, Partisani M, Hess-Kempf G, Krantz V, Priester M, Cheneau C, Bernard-Henry C, de Mautort E, Decroix L, Lang JM.

J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1454-6.

PMID:
15602122
43.

The GDP-bound form of Arf6 is located at the plasma membrane.

Macia E, Luton F, Partisani M, Cherfils J, Chardin P, Franco M.

J Cell Sci. 2004 May 1;117(Pt 11):2389-98.

44.

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D; Clinical Epidemiology Group from the French Hospital Database.

AIDS. 2003 Nov 21;17(17):2479-86.

PMID:
14600519
45.

Assisted reproduction techniques for HIV serodiscordant couples: 18 months of experience.

Ohl J, Partisani M, Wittemer C, Schmitt MP, Cranz C, Stoll-Keller F, Rongieres C, Bettahar-Lebugle K, Lang JM, Nisand I.

Hum Reprod. 2003 Jun;18(6):1244-9.

PMID:
12773453
46.

[Structured therapeutic interruption in patients infected with HIV-1 experiencing a block in their antiretroviral treatment: preliminary results].

Rey D, Schmitt MP, Hess-Kempf G, Krantz V, Partisani M, Bernard-Henry C, Lang JM.

Pathol Biol (Paris). 2001 Sep;49(7):559-66. French.

PMID:
11642019
47.

Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: a median follow-up of 64 weeks.

Rey D, Schmitt MP, Partisani M, Hess-Kempf G, Krantz V, de Mautort E, Bernard-Henry C, Priester M, Cheneau C, Lang JM.

J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):459-62.

PMID:
11511822
48.

[Multicenter study of intrafamilial transmission of hepatitis C virus in human immunodeficiency virus infection].

Huët C, Dabis F, Saillour F, Trimoulet P, Morlat P, Rispal P, Dupon M, De La Taille C, Partisani M, Bertrand M, Ragnaud JM, Couzigou P.

Gastroenterol Clin Biol. 2000 Jun-Jul;24(6-7):611-7. French.

49.

Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study.

Saint-Marc T, Partisani M, Poizot-Martin I, Rouviere O, Bruno F, Avellaneda R, Lang JM, Gastaut JA, Touraine JL.

AIDS. 2000 Jan 7;14(1):37-49.

PMID:
10714566
50.

[Emergence of resistant hepatitis B virus strains during long-term lamivudine therapy in human immunodeficiency virus co-infected patients].

Rey D, Fritsch S, Schmitt C, Partisani M, Kempf-Durepaire G, Nicolle M, Krantz V, De Mautort E, Stoll-Keller F, Lang JM.

Gastroenterol Clin Biol. 2000 Jan;24(1):125-7. French.

Supplemental Content

Loading ...
Support Center